Helping to share the web since 1996
Pilaralisib is a Class 1 phosphatidylinositol 3 kinase (PI3K) family inhibitor. It is an orally bioavailable small molecule, targeting the class I PI3K family of lipid kinases. It is a pyrimidine derivatives compound discovered by Exelixis Inc.
https://www.bocsci.com/xl147-cas-956958-53-5-item-258924.htmlalexdean2017 can login to edit this page by adding news and offers from their website.